[Tree] Hope for potential vaccines and antibiotics against antibiotic-resistant bacteria, Discovery of new species of bacteria, Evolution of human immune system in post-Omicron era, Israeli algorithm for antibody humanization, Novel strategy for battling bacterial infections, Virus-fighting cells in the lungs during flu infections, Breakthrough discovery in cystic fibrosis research, Pioneering spirit in RSV vaccine development

Version 0.22 (2024-06-24 15:57:08.256000)

updates: Britain chooses Pfizer's RSV vaccine over GSK's

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.21 (2024-03-04 20:29:45.439000)

updates: New information on Barney Graham's breakthrough in RSV vaccine development

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.2 (2024-02-23 05:39:28.213000)

updates: New discovery in cystic fibrosis research

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.19 (2024-02-21 11:43:41.918000)

updates: Addition of a breakthrough rapid test for Group B Streptococcus infection in newborns

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.18 (2024-02-15 02:14:12.608000)

updates: Discovery of virus-fighting cells in lungs during flu infections

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.17 (2024-02-06 22:11:30.515000)

updates: Addition of a novel strategy for battling bacterial infections

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.16 (2024-02-05 20:48:05.092000)

updates: Inclusion of Israeli algorithm for antibody humanization

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.15 (2024-01-21 00:10:13.932000)

updates: Integration of new information about the evolution of the human immune system in response to new SARS-CoV-2 variants

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.14 (2024-01-09 07:17:54.121000)

updates: Addition of information about the discovery of 35 new species of bacteria

  • ➔
  • ➔
  • ➔
Version 0.13 (2024-01-07 19:41:33.490000)

updates: Integration of a revolutionary antibiotic development against Mycobacterium abscessus

  • ➔
  • ➔
Version 0.12 (2023-12-13 09:59:46.220000)

updates: The development of a potential vaccine against antibiotic-resistant enterococci

  • ➔
Version 0.11 (2023-11-29 04:16:28.768000)

updates: Added information about antibiotic resistance and its causes

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.1 (2023-11-25 10:21:38.450000)

updates: Integration of information about bacteria's memory capacity and behavior

  • ➔
  • ➔
  • ➔
Version 0.09 (2023-11-23 16:07:51.488000)

updates: The new information highlights the role of pollution from various sectors in driving antimicrobial resistance, as well as the global efforts to raise awareness and combat AMR.

  • ➔
  • ➔
Version 0.08 (2023-11-22 05:02:08.926000)

updates: The Nigeria Centre for Disease Control and Prevention (NCDC) warns that the impact of Antimicrobial Resistance (AMR) on the economy, health systems, and the attainment of the Sustainable Development Goals (SDGs) is significant. The global gross domestic product could lose up to US$100 trillion by 2050 due to AMR, with low and middle-income countries being most affected. AMR directly causes 1.27 million deaths annually, with nearly 90 percent of the direct death toll occurring in low and middle-income countries. Children under five account for over 99.5 percent of AMR-related deaths. Nigeria has implemented an AMR surveillance network, antimicrobial stewardship, and awareness programs to combat the issue. The country is finalizing its second National Action Plan for AMR (NAP 2.0) and has improved its AMR multisectoral coordination and antimicrobial stewardship. The World Health Organization (WHO) representative in Nigeria states that AMR is a major contributor to overall and child mortality in the country, with a projected GDP loss of 5-7 percent by 2050.

  • ➔
  • ➔
Version 0.07 (2023-11-21 23:39:01.833000)

updates: Incorporated new study on bacteria's memory capacity and its role in antibiotic resistance

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.06 (2023-11-20 21:10:27.638000)

updates: Incorporated information about the threat of drug-resistant superbugs to the global economy, with Nigeria among the worst affected countries

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2023-11-19 07:30:31.684000)

updates: Includes information about Resistomap's funding and biosecurity intelligence platform

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2023-11-13 02:53:38.097000)

updates: Expanded the narrative to include microbial genome editing and its connection to renewable fuel production.

  • ➔
  • ➔
  • ➔
Version 0.03 (2023-11-13 01:08:11.518000)

updates: Restructured and combined information from multiple sources to create a cohesive narrative.

  • ➔
  • ➔
  • ➔
Version 0.02 (2023-11-12 06:36:41.838000)

updates: Restructured and expanded content to include information on open science initiatives, computer science success, and cellular reprogramming for age reversal

  • ➔
  • ➔
Version 0.01 (2023-11-02 03:46:12.453000)

updates: Restructured and streamlined information

  • ➔
Version 0.0 (2023-10-24 14:46:11.751000)

updates:

  • ➔
  • ➔